FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to vaccinology and cell biology.
EFFECT: what is presented is a method for preparing the cytomegalovirus vaccine ensured by specifying a cell type wherein this virus replicates; the vaccine and method for immunising an individual against CMV.
19 cl, 6 dwg, 5 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| CONDITIONALLY REPLICATING CYTOMEGALOVIRUS AS VACCINE AGAINST CMV | 2012 |
|
RU2611198C2 |
| CONDITIONALLY REPLICATING CYTOMEGALOVIRUS AS VACCINE AGAINST CMV | 2012 |
|
RU2670012C1 |
| COMPOSITIONS AND METHODS FOR TREATING CYTOMEGALOVIRUS | 2012 |
|
RU2737530C1 |
| METHODS FOR DETECTION OF ANTI-CYTOMEGALOVIRUS NEUTRALIZING ANTIBODIES | 2013 |
|
RU2660712C2 |
| MUTANT GP 50 FOR VECTOR VACCINE PREPARING, VECTOR VACCINE ANDMUTANT GP 50 FOR VECTOR VACCINE PREPARING, VECTOR VACCINE AND METHOD OF ITS PRODUCING | 1993 |
|
RU2158308C2 |
| IMPROVED ND-IBD VACCINE BASED ON HVT VECTOR | 2015 |
|
RU2692013C2 |
| RECOMBINANT NONPATHOGENIC MDV VECTOR PROVIDING POLY-SPECIFIC IMMUNITY | 2012 |
|
RU2593950C2 |
| IMMUNOGENIC COMPOSITION BASED ON CONDITIONALLY LIVE VIRION AND METHOD FOR MAKING THEREOF | 2006 |
|
RU2415933C2 |
| IMMUNOGENIC COMPOSITION AND METHOD OF FUSED PROTEIN VACCINE DEVELOPMENT | 2004 |
|
RU2407749C2 |
| STRAIN OF SINDBIS FEVER VIRUS 1383 CLONE 3 | 2018 |
|
RU2720518C1 |
